Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma characterized by the presence of circulating plasma cells. This consensus statement, produced by the International Myeloma Working Group, proposes that the thresholds for diagnosis be re-examined and make recommendations for diagnosis, treatment as well as, response and progression criteria.